+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Therapeutic Plasma Exchange - Market Analysis, Trends, and Forecasts

  • ID: 4806278
  • Report
  • 141 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Asahi Kasei Medical
  • B. Braun Melsungen Ag
  • Baxter International
  • Fenwal, Inc.
  • Fresenius Se & Co. Kgaa
  • Haemonetics Corporation
  • MORE
Therapeutic Plasma Exchange market worldwide is projected to grow by US$663.8 Million, driven by a compounded growth of 7%. Neurological Disorders, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$616 Million by the year 2025, Neurological Disorders will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$30.1 Million to the region's size and clout in the next 5 to 6 years. Over US$31.1 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Neurological Disorders will reach a market size of US$56.2 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.7% over the next couple of years and add approximately US$113.8 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fenwal, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Kawasumi Laboratories, Inc.
  • Terumo BCT, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Asahi Kasei Medical
  • B. Braun Melsungen Ag
  • Baxter International
  • Fenwal, Inc.
  • Fresenius Se & Co. Kgaa
  • Haemonetics Corporation
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Therapeutic Plasma Exchange Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Therapeutic Plasma Exchange Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 2: Therapeutic Plasma Exchange Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017

TABLE 3: Therapeutic Plasma Exchange Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Hospitals (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2018 through 2025

TABLE 5: Hospitals (End-Use) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2009 to 2017

TABLE 6: Hospitals (End-Use) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025

TABLE 7: Specialty Clinics (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025

TABLE 8: Specialty Clinics (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017

TABLE 9: Specialty Clinics (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 10: Ambulatory Surgical Centers (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025

TABLE 11: Ambulatory Surgical Centers (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2009-2017

TABLE 12: Ambulatory Surgical Centers (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025

TABLE 13: Neurological Disorders (Disease Indication) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 14: Neurological Disorders (Disease Indication) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 15: Neurological Disorders (Disease Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Renal Disorders (Disease Indication) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 17: Renal Disorders (Disease Indication) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017

TABLE 18: Renal Disorders (Disease Indication) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 19: Hematology Disorders (Disease Indication) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025

TABLE 20: Hematology Disorders (Disease Indication) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017

TABLE 21: Hematology Disorders (Disease Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Metabolic Disorders (Disease Indication) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025

TABLE 23: Metabolic Disorders (Disease Indication) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017

TABLE 24: Metabolic Disorders (Disease Indication) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Other Disease Indications (Disease Indication) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 26: Other Disease Indications (Disease Indication) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 27: Other Disease Indications (Disease Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Therapeutic Plasma Exchange Market Share (in %) by Company: 2019 & 2025

TABLE 28: United States Therapeutic Plasma Exchange Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025

TABLE 29: Therapeutic Plasma Exchange Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2009-2017

TABLE 30: Therapeutic Plasma Exchange Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025

TABLE 31: United States Therapeutic Plasma Exchange Market Estimates and Projections in US$ Thousand by Disease Indication: 2018 to 2025

TABLE 32: Therapeutic Plasma Exchange Market in the United States by Disease Indication: A Historic Review in US$ Thousand for 2009-2017

TABLE 33: United States Therapeutic Plasma Exchange Market Share Breakdown by Disease Indication: 2009 VS 2019 VS 2025

CANADA

TABLE 34: Canadian Therapeutic Plasma Exchange Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025

TABLE 35: Therapeutic Plasma Exchange Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017

TABLE 36: Canadian Therapeutic Plasma Exchange Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

TABLE 37: Canadian Therapeutic Plasma Exchange Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018 to 2025

TABLE 38: Canadian Therapeutic Plasma Exchange Historic Market Review by Disease Indication in US$ Thousand: 2009-2017

TABLE 39: Therapeutic Plasma Exchange Market in Canada: Percentage Share Breakdown of Sales by Disease Indication for 2009, 2019, and 2025

JAPAN

TABLE 40: Japanese Demand Estimates and Forecasts for Therapeutic Plasma Exchange in US$ Thousand by End-Use: 2018 to 2025

TABLE 41: Japanese Therapeutic Plasma Exchange Market in US$ Thousand by End-Use: 2009-2017

TABLE 42: Therapeutic Plasma Exchange Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025

TABLE 43: Japanese Market for Therapeutic Plasma Exchange: Annual Sales Estimates and Projections in US$ Thousand by Disease Indication for the Period 2018-2025

TABLE 44: Therapeutic Plasma Exchange Market in Japan: Historic Sales Analysis in US$ Thousand by Disease Indication for the Period 2009-2017

TABLE 45: Japanese Therapeutic Plasma Exchange Market Share Analysis by Disease Indication: 2009 VS 2019 VS 2025

CHINA

TABLE 46: Chinese Demand for Therapeutic Plasma Exchange in US$ Thousand by End-Use: 2018 to 2025

TABLE 47: Therapeutic Plasma Exchange Market Review in China in US$ Thousand by End-Use: 2009-2017

TABLE 48: Chinese Therapeutic Plasma Exchange Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025

TABLE 49: Chinese Therapeutic Plasma Exchange Market Growth Prospects in US$ Thousand by Disease Indication for the Period 2018-2025

TABLE 50: Therapeutic Plasma Exchange Historic Market Analysis in China in US$ Thousand by Disease Indication: 2009-2017

TABLE 51: Chinese Therapeutic Plasma Exchange Market by Disease Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Therapeutic Plasma Exchange Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 52: European Therapeutic Plasma Exchange Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025

TABLE 53: Therapeutic Plasma Exchange Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017

TABLE 54: European Therapeutic Plasma Exchange Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 55: European Therapeutic Plasma Exchange Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025

TABLE 56: Therapeutic Plasma Exchange Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017

TABLE 57: European Therapeutic Plasma Exchange Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

TABLE 58: European Therapeutic Plasma Exchange Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018-2025

TABLE 59: Therapeutic Plasma Exchange Market in Europe in US$ Thousand by Disease Indication: A Historic Review for the Period 2009-2017

TABLE 60: European Therapeutic Plasma Exchange Market Share Breakdown by Disease Indication: 2009 VS 2019 VS 2025

FRANCE

TABLE 61: Therapeutic Plasma Exchange Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2018-2025

TABLE 62: French Therapeutic Plasma Exchange Historic Market Review in US$ Thousand by End-Use: 2009-2017

TABLE 63: French Therapeutic Plasma Exchange Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025

TABLE 64: Therapeutic Plasma Exchange Market in France by Disease Indication: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 65: French Therapeutic Plasma Exchange Historic Market Scenario in US$ Thousand by Disease Indication: 2009-2017

TABLE 66: French Therapeutic Plasma Exchange Market Share Analysis by Disease Indication: 2009 VS 2019 VS 2025

GERMANY

TABLE 67: Therapeutic Plasma Exchange Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025

TABLE 68: German Therapeutic Plasma Exchange Market in Retrospect in US$ Thousand by End-Use: 2009-2017

TABLE 69: Therapeutic Plasma Exchange Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025

TABLE 70: Therapeutic Plasma Exchange Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Disease Indication for the Period 2018-2025

TABLE 71: German Therapeutic Plasma Exchange Historic Market Analysis in US$ Thousand by Disease Indication: 2009-2017

TABLE 72: German Therapeutic Plasma Exchange Market Share Breakdown by Disease Indication: 2009 VS 2019 VS 2025

ITALY

TABLE 73: Italian Demand for Therapeutic Plasma Exchange in US$ Thousand by End-Use: 2018 to 2025

TABLE 74: Therapeutic Plasma Exchange Market Review in Italy in US$ Thousand by End-Use: 2009-2017

TABLE 75: Italian Therapeutic Plasma Exchange Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025

TABLE 76: Italian Therapeutic Plasma Exchange Market Growth Prospects in US$ Thousand by Disease Indication for the Period 2018-2025

TABLE 77: Therapeutic Plasma Exchange Historic Market Analysis in Italy in US$ Thousand by Disease Indication: 2009-2017

TABLE 78: Italian Therapeutic Plasma Exchange Market by Disease Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 79: United Kingdom Demand Estimates and Forecasts for Therapeutic Plasma Exchange in US$ Thousand by End-Use: 2018 to 2025

TABLE 80: United Kingdom Therapeutic Plasma Exchange Market in US$ Thousand by End-Use: 2009-2017

TABLE 81: Therapeutic Plasma Exchange Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025

TABLE 82: United Kingdom Market for Therapeutic Plasma Exchange: Annual Sales Estimates and Projections in US$ Thousand by Disease Indication for the Period 2018-2025

TABLE 83: Therapeutic Plasma Exchange Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Disease Indication for the Period 2009-2017

TABLE 84: United Kingdom Therapeutic Plasma Exchange Market Share Analysis by Disease Indication: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 85: Rest of Europe Therapeutic Plasma Exchange Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025

TABLE 86: Therapeutic Plasma Exchange Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017

TABLE 87: Rest of Europe Therapeutic Plasma Exchange Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

TABLE 88: Rest of Europe Therapeutic Plasma Exchange Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018-2025

TABLE 89: Therapeutic Plasma Exchange Market in Rest of Europe in US$ Thousand by Disease Indication: A Historic Review for the Period 2009-2017

TABLE 90: Rest of Europe Therapeutic Plasma Exchange Market Share Breakdown by Disease Indication: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 91: Therapeutic Plasma Exchange Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2018-2025

TABLE 92: Asia-Pacific Therapeutic Plasma Exchange Historic Market Review in US$ Thousand by End-Use: 2009-2017

TABLE 93: Asia-Pacific Therapeutic Plasma Exchange Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025

TABLE 94: Therapeutic Plasma Exchange Market in Asia-Pacific by Disease Indication: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 95: Asia-Pacific Therapeutic Plasma Exchange Historic Market Scenario in US$ Thousand by Disease Indication: 2009-2017

TABLE 96: Asia-Pacific Therapeutic Plasma Exchange Market Share Analysis by Disease Indication: 2009 VS 2019 VS 2025

REST OF WORLD

TABLE 97: Rest of World Therapeutic Plasma Exchange Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025

TABLE 98: Therapeutic Plasma Exchange Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017

TABLE 99: Rest of World Therapeutic Plasma Exchange Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

TABLE 100: Rest of World Therapeutic Plasma Exchange Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018 to 2025

TABLE 101: Rest of World Therapeutic Plasma Exchange Historic Market Review by Disease Indication in US$ Thousand: 2009-2017

TABLE 102: Therapeutic Plasma Exchange Market in Rest of World: Percentage Share Breakdown of Sales by Disease Indication for 2009, 2019, and 2025

IV. COMPETITION

ASAHI KASEI MEDICAL

B. BRAUN MELSUNGEN AG

BAXTER INTERNATIONAL

FENWAL, INC.

FRESENIUS SE & CO. KGAA

HAEMONETICS CORPORATION

HEMACARE CORPORATION

KAWASUMI LABORATORIES

TERUMO BCT

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Asahi Kasei Medical
  • B. Braun Melsungen Ag
  • Baxter International
  • Fenwal, Inc.
  • Fresenius Se & Co. Kgaa
  • Haemonetics Corporation
  • Hemacare Corporation
  • Kawasumi Laboratories
  • Terumo Bct
Note: Product cover images may vary from those shown
Adroll
adroll